SYM Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$907K Buy
14,532
+520
+4% +$32.9K 0.07% 87
2026
Q2
$807K Sell
14,012
-17
-0.1% -$976 0.06% 85
2026
Q1
$851K Buy
14,029
+1,900
+16% +$111K 0.09% 69
2025
Q4
$654K Buy
12,129
+4,591
+61% +$221K 0.07% 91
2025
Q3
$340K Sell
7,538
-1,047
-12% -$48.9K 0.04% 190
2025
Q2
$397K Sell
8,585
-307
-3% -$15.1K 0.04% 156
2025
Q1
$542K Sell
8,892
-198
-2% -$11.5K 0.07% 100
2024
Q4
$514K Buy
9,090
+1,348
+17% +$75.3K 0.07% 89
2024
Q3
$401K Sell
7,742
-522
-6% -$24.5K 0.05% 88
2024
Q2
$343K Buy
+8,264
New +$370K 0.05% 85

Other funds holding BMY

SYM Financial Corp's BMY Position: Q3 2026 in Review

SYM Financial Corp increased its Bristol-Myers Squibb (BMY) stake by 3.7% in Q3 2026, buying an estimated $32.9K and bringing the position to 14,532 shares worth $907K. The position accounts for 0.07% of the portfolio, ranked #87.

SYM Financial Corp first reported a position in BMY in Q2 2024 and has held it in 10 quarters since. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • SYM Financial Corp held 14,532 shares of Bristol-Myers Squibb worth $907K as of Q3 2026.
  • SYM Financial Corp bought 520 Bristol-Myers Squibb shares in Q3 2026, an estimated $32.9K.
  • Bristol-Myers Squibb made up 0.07% of SYM Financial Corp's portfolio in Q3 2026, its #87 holding.
  • SYM Financial Corp first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 10 quarters since.
  • 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on SYM Financial Corp's 13F filing for Q3 2026, filed 26 Oct 2026.